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B Cell Responses to a Peptide Epitope. X. Epitope Selection in
a Primary Response Is Thermodynamically Regulated1
Pooja Nakra,* Venkatasamy Manivel,* Ram A. Vishwakarma,† and Kanury V. S. Rao2*
We examine the etiological basis of hierarchical immunodominance of B cell epitopes on a multideterminant Ag. A model
T-dependant immunogen, containing a single immunodominant B cell epitope, was used. The primary IgM response to this peptide
included Abs directed against diverse determinants presented by the peptide. Interestingly, affinity of individual monomeric IgM
Abs segregated around epitope recognized and was independent of their clonal origins. Furthermore, affinity of Abs directed
against the immunodominant epitope were markedly higher than that of the alternate specificities. These studies suggested that
the affinity of an epitope-specific primary response, and variations therein, may be determined by the chemical composition of
epitope. This inference was supported by thermodynamic analyses of monomer IgM binding to Ag, which revealed that this
interaction occurs at the expense of unfavorable entropy changes. Permissible binding required compensation by net enthalpic
changes. Finally, the correlation between chemical composition of an epitope, the resultant affinity of the early primary humoral
response, and its eventual influence on relative immunogenicity could be experimentally verified. This was achieved by examining
the effect of various amino-terminal substitutions on immunogenicity of a, hitherto cryptic, amino-terminal determinant. Such
experiments permitted delineation of a hierarchy of individual amino acid residues based on their influence; which correlated well
with calculated Gibbs-free energy changes that individual residue side chains were expected to contribute in a binding interaction.
Thus, maturation of a T-dependant humoral response is initiated by a step that is under thermodynamic control. The Journal
of Immunology, 2000, 164: 5615–5625.
T he stochastic processes which drive both gene segmentrearrangements and subsequent pairing in the generationof Ag receptors equip the host with a preimmune B cell
repertoire that is collectively capable of recognizing a virtually
limitless array of antigenic determinants (1, 2). It was this realiza-
tion, along with the fact that B cells generally recognize protein
Ags in their native form, that has led to the proposition that the
entire accessible surface of a protein potentially represents an an-
tigenic continuum (3).
Although the above notion represents a logical derivative of our
understanding of parameters regulating B cell responses, it, how-
ever, appears to be inconsistent with experimental observations.
Characterization of immune responses to a variety of protein Ags
has revealed that only a fraction of the repertoire of B cell epitopes
presented by such Ags is functionally capable of eliciting Abs
(4–13). Some insight into this apparent discrepancy was provided
by our own studies employing synthetic peptides as model T-de-
pendent Ags (13–15). These investigations revealed that the pri-
mary IgM response was indeed consistent with expectations in that
Abs were produced against all accessible domains on Ag (14).
Interestingly however, these early activated clonotypes were soon
subjected to a stringent selection process which ensured continued
survival of only those induced B cells with a high enough affinity
for Ag (14). This selection process preceded initiation of the ger-
minal center (GC)3 reaction, and was enforced by the need for the
diverse Ag-activated B cells to compete for a limiting pool of
Ag-primed Th cells (14). Although the precise mechanism is un-
clear, affinity for Ag was found to be crucial in defining ability of
the individual clonotypes to recruit T cell help in a competitive
milieu (14). Only those Ag-activated B cells selected at this stage
were shown to be permitted to populate GCs, thereby influencing
the character of secondary responses (16, 17). These observations
could also be complemented, at the cellular level, by our demon-
stration that differential Th cell thresholds operate during Ag-
driven activation of preimmune B cells and the subsequent selec-
tion step that restricts clonotype seeding of GCs (17, 18).
It is obvious, therefore, that the pre-GC phase selection process
outlined above constitutes the first active step initiating maturation
of T-dependent humoral responses to multideterminant Ags. How-
ever, although cellular interactions that drive this process were
becoming apparent, there was one important facet that remained
unresolved. This related to the question of whether there were any
underlying factors regulating the affinity of Abs recruited from a
pool of stochastically generated receptors. This issue became par-
ticularly relevant in light of our observations of an intriguing par-
allel wherein Ag-affinity dependent pre-GC phase selection also
simultaneously resulted in a “filtering” of epitopes recognized on
Ag (14, 17). Furthermore, relative immunodominance of an indi-
vidual epitope subsequently proved to be resistant to a variety of
predictable variables such as mouse H-2 haplotype, nature of
flanking domains, positional effects, varying degrees of conforma-
tional flexibility, as well as any restriction at the level of B cell
repertoires induced against it (13–15, 19). These and related results
suggested, to us, that the affinity of early primary responses may be
epitope dependent. In other words, the chemical composition of a
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given epitope may constitute at least one parameter that dictates
the affinity of primary Ab responses elicited against it.
The present set of investigations was, therefore, undertaken with
the objective of verifying the above possibility. Results presented
here, indeed, argue in favor of such a correlation. Furthermore,
they also establish the functional significance of such distinctions
in epitope-specific early primary Ab affinities, by demonstrating
that they impinge upon the hierarchy of epitopic dominance ob-
served in the later stages of humoral responses.
Materials and Methods
Materials
Heavy chain-specific, HRP-labeled, goat anti-mouse IgM and IgG were
purchased from Sigma (St. Louis, MO). Anti-B7-2 (clone GL1) was pur-
chased from PharMingen (San Diego, CA). For multipin synthesis of pep-
tides, both the noncleavable kits and F-moc amino acid derivatives were
obtained from Chiron Mimotopes (Victoria, Australia).
Peptide synthesis
Peptide PS1CT3 and all its analogues used in this study were synthesized
by the solid-phase method (20, 21) using F-moc chemistry (22) on a Mil-
ligen 9050 automated peptide synthesizer (Millipore, Bedford, MA). Crude
peptides were purified to at least 95% purity by reverse-phase HPLC on a
C18 column (15m d pak, 19 3 300 mm; Waters, Milford, MA) using an
aqueous gradient of 0–70% acetonitrile in 0.1% trifluoroacetic acid. The
identities of all peptides were ascertained by mass spectrometry.
Overlapping hexapeptide panels were synthesized according to the
method of Geysen et al. (23) on noncleavable multipin kits. For synthesis,
the standard protocol recommended by the manufacturer was adhered to.
After completion of synthesis, all peptides were routinely acetylated at the
amino terminus with a 50:5:1 (v/v/v) mixture of dimethylformamide, acetic
anhydride, and triethylamine. Side chain deprotection was accomplished
over a 2-h period at room temperature with a 38:1:1 (v/v/v) mixture of
trifluoroacetic acid, ethanedithiol, and anisole.
Animals and immunizations
Female BALB/c mice (6–8 wk old) were obtained from the small animal
facility at the National Institute of Nutrition (Hyderabad, India). Except
where stated, immunizations were generally given i.p. at a dose of 50
mg/mouse as an emulsion in CFA. For polyclonal sera, mice were bled
from the retro-orbital plexus, and sera within a group were pooled. In all
cases, the IgM and IgG fractions were separated by passing over a protein
G-Sepharose column (Pharmacia, Uppsala, Sweden). The flow through
contained IgM, whereas bound IgG, after thorough washing of the column,
was eluted with glycine-HCl buffer (pH 2.7). The eluate was immediately
neutralized, concentrated, and then dialyzed against PBS before use.
Affinity purification of Abs
All IgM mAbs described were obtained as ascites from hybridomas that
had been generated earlier (14, 15). These mAbs represent primary IgM
responses to the PS1 segment at 4 days after a primary immunization of
BALB/c mice (14, 15). Each of the IgM preparations was purified by
affinity chromatography over an Affi-Gel 10 Gel (Bio-Rad, Hercules, CA)
column coupled to peptide PS1CT3 at 10 mg/ml of gel. The ascites prep-
aration was incubated with the affinity matrix overnight at 4°C on a rotating
shaker. After this, the flow through was removed and the column was
washed with 10 column volumes of PBS (pH 7.2), followed by 10 column
volumes of phosphate buffer containing 1 M NaCl, and finally again with
5 column volumes of PBS. Bound IgM was then eluted in glycine-HCl
buffer (pH 2.7) and then immediately neutralized with 1 M Tris buffer (pH
8.0). The neutralized eluate was subjected to buffer exchange into 0.5 M
Tris buffer containing 2 mM EDTA (pH 8.0) and concentrated to a final
IgM concentration of 10 mg/ml. Purity of the IgM fraction was ascertained
by SDS-PAGE.
For peptide-specific polyclonal IgM, sera were first depleted of IgG Abs
by two rounds of incubation with protein G-Sepharose. The flow through
fraction was further enriched for IgM by chromatography over DEAE-
cellulose (Sigma). The IgM-containing fraction was then purified by af-
finity chromatography for Abs specific either for peptide PS1CT3 or, as
required, its analogues as described above.
Preparation of monomeric IgMs
This was essentially achieved using a standard protocol (24). Briefly, af-
finity-purified IgM Abs obtained above were reduced with a final concen-
tration of 1 mM DTT at room temperature for 1 h with gentle shaking.
After this, reduced IgM was alkylated with a final concentration (added in
one-tenth the volume) of 2.1 mM iodoacetamide in the dark at 4°C for 30
min. At the end of this period, the mixture was resolved over a Sephadex
G-200 column (Sigma; column dimensions, 25 cm 3 1.5 cm; load volume,
0.5 ml) using blue dextran as a marker for the void volume. Fractions
containing monomeric IgM, which elutes immediately following the void
volume, were pooled and concentrated to between 10 and 40 mg/ml in PBS
containing 0.05% Tween 20. Ab concentrations were determined spectro-
photometrically by measuring absorbance at 280 nm. An average molec-
ular mass of 200 kDa was taken for monomeric IgM (24).
Analysis of monomeric IgM binding to peptide PS1CT3
Monomeric mAb binding to peptide PS1CT3 was examined according to
the technique of surface plasmon resonance on an Iasys Auto1 instrument
(Affinity Sensors, Cambridge, U.K.). Peptide was immobilized onto car-
boxymethyl dextran cuvettes using the protocol recommended by the man-
ufacturer. Ab binding to immobilized peptide was monitored at multiple
Ab concentrations, ranging from 5-fold below to at least 5-fold above
preliminary estimates of equilibrium dissociation constants (Kd) for each
mAb. All reactions were conducted at 25°C. Association was monitored
over a period of 7–10 min, whereas dissociation was monitored for 5 min.
Kinetic analysis was performed using the FASTfit software (Affinity Sen-
sors, Cambridge, U.K.) provided by the manufacturer, which provided the
values of kon and kdiss at each Ab concentration. Second-order association
rate constants (kass) were then obtained from a linear regression plot of kon
vs Ab concentration, again using the FASTfit software. Equilibrium affinity
constants (Ka) were then derived, for each mAb, from the equation: Ka 5
kass/kdiss.
For a thermodynamic analysis of peptide-mAb association, monomer
Abs were used at a single concentration that was 5-fold above its Kd value.
The association reaction for each mAb was studied, as described above, at
four different temperatures of 20, 25, 30, and 35°C. The corresponding kon
values were obtained, from which the apparent association rate constant for
each Ab at each temperature was obtained by dividing it with Ab
concentration.
ELISAs
Plates were coated with 2 mg/ml of peptide per well in 100 ml of PBS (pH
7.2) at 37°C for 3.5 h. Subsequently, they were blocked with 300 ml/well
of a 5% solution of fat-free dry milk powder in PBS at 37°C for 1 h. Then
100 ml of the appropriate dilution of mouse antiserum was added and
incubated at 37°C for 1 h. After washing, bound Ab was detected with
HRP-labeled secondary Ab (37°C, 1 h), followed by color development
with o-phenylenediamine as chromogen. Absorbance was measured at 490
nm, and background absorbance obtained for preimmune serum at the cor-
responding dilution was subtracted.
For competitive ELISA experiments, the procedure described earlier
was followed (14, 19). Briefly, the purified IgG fraction, at concentrations
2-fold that of the 50% titer value, was mixed with appropriated concen-
trations of competitor peptide in equal volumes and incubated for 10 min
at room temperature. This was then added to duplicate wells at 100 ml/well.
The remaining procedure is as described above.
ELISAs for pin-bound hexapeptides
Ab cross-reactivity with pin-bound hexapeptides was also evaluated by
ELISA. For this, the protocol recommended by the manufacturer was
strictly followed. Primary Abs were diluted appropriately in PBS contain-
ing 2% BSA, 0.1% Tween 29, and 0.1% sodium azide. Pins were incubated
in 200 ml each of the Ab solution at 4°C overnight with gentle shaking.
Subsequently, they were washed and subjected to a second round of incu-
bation with the appropriate dilution of HRPO-labeled goat anti-mouse IgG
at room temperature for 1 h, again with gentle shaking. The chromogen
used for detecting bound Ab was 2,29-azino-bis-(3-ethyl-benzthiazoline-6-
sulfonic acid)diammonium, and the absorbance was measured at 405 nm
after subtracting the background at 490 nm.
Calculation of amino acid side chain DG values
Specific side chain contribution from residues in interacting domains de-
rives from two distinct types of interactions: hydrophobic and electrostatic.
If one assumes that side chain entropy changes, when engaged in an in-
teraction, are negligible, the Gibbs-free energy changes (DG) accompany-
ing idealized interactions for a given residue side chain can be described as,
DGtotal 5 DGHB 1 DGEL (25). Here, DGHB represents the energy released
through hydrophobic interactions and has been estimated to be 225 cal/
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mol/A2 of surface area (25, 26). Since side chain area for all individual
residues are known (26), DGHB is easily calculated. DGEL represents the
enthalpy change due to electrostatic interactions. For the present case,
where we have assumed idealized interactions, the maximal value of 25.0
kcal/mol was taken for each salt-bridging interaction (27). Thus, from the
values of DGHB and DGEL, DGtotal was easily calculated for each individual
amino acid residue side chain.
Results
Characterization of primary IgM responses to peptide PS1CT3
We continued to employ the model peptide PS1CT3 for our cur-
rent studies. As previously described (14), this peptide represents
a T-dependent immunogen and is comprised of a well-character-
ized B (residues 1–15, segment PS1) and a T (residues 18–38,
segment CT3) cell epitope. Separating these two domains is a
spacer of two glycine residues at positions 16 and 17 (Fig. 1). Our
earlier results have demonstrated that the murine primary IgM re-
sponse to this peptide was composed of individual Ab specificities
that collectively spanned the entire PS1 segment (14). Interest-
ingly, however, subsequent class switch to IgG was restricted to
only those Ab subsets directed against a unique tetrapeptide
epitope between positions 4 and 7 of the PS1 segment (sequence:
DPAF, Fig. 1) (14). This apparent monospecificity, which derived
from an oligoclonal B cell population, was also shown to be re-
tained in the secondary IgG response (14, 19, 28).
In the course of our earlier characterization of the murine pri-
mary immune responses to the PS1 segment, we had generated a
panel of IgM class mAbs derived from fusions performed at 4 days
after a primary immunization of BALB/c mice (14, 15). Subse-
quent epitope-mapping studies had confirmed that these mAbs
constituted a heterogenous set, including specificities for a diverse
set of determinants within the PS1 segment as shown in Fig. 1. As
an initial exploration, we asked whether these individual mAbs
displayed any qualitative differences in binding to their respective
epitopes on peptide PS1CT3. To do this, however, we first per-
formed a reduction reaction on each of these IgM mAbs to obtain
monomeric IgMs (see Materials and Methods). The objective in
doing this was 2-fold. At one level it was expected that a bivalent
IgM molecule would allow for a greater degree of resolution of
differences in Ag-binding properties that might normally be
masked due to the increased valency of pentameric IgM. More
importantly though, we reasoned that monomeric IgM would also
be reminiscent of the surface (s) IgM receptor on preimmune B
cells, thereby providing an insight into Ag recognition by preim-
mune B cells.
Each of the individual monomeric IgM preparations obtained
were subsequently analyzed for their concentration-dependent
binding to peptide PS1CT3. For this, we employed the technique
of surface plasmon resonance (see Materials and Methods), and
representative data for one such monomeric IgM preparation is
shown in Fig. 2. Analyses of these data yielded values for the
association (kass) and dissociation (kdiss) rate constants, from which
the equilibrium affinity constant (Ka) could readily be determined
for each mAb as described in Materials and Methods. The mono-
meric IgM preparations analyzed, their corresponding epitope
specificities, as well as their Ag-binding properties are listed in
Table I. At the first glance, it is interesting to note that this mono-
mer mAb panel represents a wide distribution of affinities with Ka
values ranging from 104 to 106 M21 (Table I). Considering that
these mAbs were derived from B cells actively participating in a
primary response (14, 15), these results would then suggest that
Ag-binding affinity constants of as low as 104 M21 are sufficient to
induce preimmune B cells into a primary Ag-specific IgM re-
sponse. This is entirely consistent with our previous demonstration
that induction of a primary IgM response involves low activation
thresholds (18).
A particularly intriguing feature of the data in Table I is the fact
that Ab affinities were not randomly distributed across the various
FIGURE 1. Amino acid sequence of peptide PS1CT3. The primary
amino acid sequence, in the single-letter code, is given for the model
peptide PS1CT3. The bars above and below the PS1 segment (residues
1–15) represent individual domains recognized by the IgM mAbs listed in
Table I.
FIGURE 2. Binding profiles of a monomeric IgM mAb to peptide
PS1CT3. Depicted are the association and dissociation curves for the in-
teraction of a representative monomeric IgM mAb (7bM) to immobilized
peptide PS1CT3 over a concentration range of 20–2000 nM. The arrows
for each plot mark commencement of the dissociation reaction. For exper-
imental details refer to Materials and Methods.
Table I. Binding properties of primary monomeric IgM mAbs to
peptide PS1CT3a
mAb Epitope Specificity
kass 3 1023
(M21s21)
kdiss 3 103
(s21)
Ka 3 1025
(M21)
605 LDPA 2.40 21.00 1.10
601 DPA 0.74 8.47 0.87
603 DPA 0.88 8.96 1.02
606 DPA 0.78 12.00 0.65
7bM DPAF 4.80 1.50 32.00
7cM DPAF 18.00 7.10 25.40
604 DPAF 18.20 9.20 19.80
16b PAF 0.27 8.00 0.34
6aM FG 0.13 3.00 0.42
613 FG 0.80 22.00 0.36
19M FG 0.85 17.90 0.47
609 NST 0.30 9.20 0.33
42M NSTN 2.10 17.00 1.20
8aM NSTN 0.19 1.40 1.36
49M NSTN 1.90 8.10 2.30
a Listed are the individual monomeric IgM preparations analyzed for peptide
PS1CT3 binding by the technique of surface plasmon resonance as described in Ma-
terials and Methods. Fine specificity of these mAbs was determined by mapping
against an overlapping PS1-derived hexapeptide panel as described previously (14).
Values given for kass and kdiss (Materials and Methods) are the mean of two separate
determinations, where the variation was ,30% in all cases. The equilibrium affinity
constant (Ka) was obtained by dividing kass with the value for kdiss (Materials and
Methods).
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epitopes but, rather, were segregated around the epitopes recog-
nized. Thus, for example, all anti-DPAF monomer IgM mAbs dis-
played comparable affinities for epitopes, which was markedly
higher than that of those directed against alternate determinants
within the PS1 segment (Table I). Similarly, the various NSTN-
specific mAbs were also comparable in their affinity for the peptide
(Table I). It must be noted here that the anti-DPAF mAbs 7bM,
7cM, and 604 derive from clonally distinct B cell precursors as
revealed by nucleotide sequencing of the Ig heavy chain variable
region genes. Thus, the predicted amino acid sequences of the
heavy chain CDR3 regions for mAbs 7bM, 7cM, and 604, respec-
tively, were as follows: QRTIGTPGAY, WAWFAY, and IPITT
ATNWYDFV (Ref. 15 and B. P. Nayak and K. V. S. Rao, un-
published results). This was also true of the anti-NSTN mAbs
42M, 49M, and 8aM where, again, nonidentical IgH CDR3 se-
quences were obtained (B. P. Nayak and K. V. S. Rao, unpublished
results). Thus, the comparable affinities displayed by mAbs di-
rected against a common epitope is not necessarily a consequence
of clonal relatedness of the B cells from which they were derived.
Association between Ag and monomeric IgMs is driven by
favorable enthalpy changes
The overall energetics and, therefore, the affinity of a binding in-
teraction is modulated by net changes in two thermodynamic pa-
rameters, namely, enthalpy and entropy. Although the enthalpy
term generally describes heat changes that take place as a conse-
quence of interactions which occur at the binding interface, en-
tropy changes largely represent net conformational/stereochemi-
cal/structural perturbations that occur either within the interacting
entities or in the surrounding solvent molecules (29, 30). There-
fore, to understand the basis of epitope-dependent distinction in
monomer IgM affinities seen in Table I, we examined the relative
roles of enthalpy and entropy in regulating association between Ab
and Ag.
All mAbs listed in Table I were extensively analyzed for con-
tribution of enthalpic and entropic parameters in binding to peptide
PS1CT3. Even though the detailed results will be presented else-
where (V. Manivel, P. Nakra, N. Sahoo, and K. V. S. Rao, manu-
script in preparation), we discuss here results obtained for the as-
sociation phase of the reaction with four representative monomeric
IgM mAbs. For this, Ab association with peptide was studied at
various temperatures and the kass value at each temperature was
determined (see Materials and Methods). Fig. 3 gives the Arrhe-
nius plot for the temperature dependence of kass for the four indi-
vidual Ab preparations. The slope of each plot yielded the activa-
tion energy (Ea) for each of the mAbs. This then permitted
calculation of the individual activation parameters for association
using equations 1–3 given below (see Ref. 31):
DH 5 Ea 2 RT (1)
ln ~kass/T! 5 2 DHass/RT 1 Sass/R 1 ln ~k9/h! (2)
DGass 5 DHass 2 TDSass (3)
In the above equations, kass represents the association rate con-
stants obtained at 25°C, T is the temperature in degrees Kelvin, k9
is the Boltzmann constant, and h is the Planck constant. Results
from such analyses for the four representative monomer IgM
mAbs are presented in Table II. It is evident from these data that,
in all cases, association of monomeric IgM with peptide is accom-
panied by large unfavorable changes in entropy as indicated by the
large negative values obtained for DSass (Table II). In contrast, the
negative DHass values clearly identify that enthalpy changes ac-
companying Ab-Ag association were highly favorable in all cases
(Table II). Similar results were obtained for all of the monomeric
IgM mAbs listed in Table I (data not shown). Consequently, the
driving force for Ag-monomeric IgM association appears to derive
from stabilizing interactions at the paratope-epitope interface, and
can occur only if these forces can compensate for the unfavorable
entropy changes that such an interaction necessitates. Because
these studies employed monomeric IgM mAbs, this interpretation
could also, in principle, be extended to apply to the sIgM receptor
on preimmune B cells.
Thus, although the data in Table I reveal the existence of a
relationship between affinity of primary recognition of Ag and the
chemical nature of the epitope recognized, results summarized in
Table II rationalize this observation by implying that this may
derive from differential epitope-dependent enthalpic contributions.
Distinctions in affinity of preimmune recognition influence
relative immunodominance in the later stages of the response
The influence of affinity of primary epitope-specific humoral re-
sponses on the eventual hierarchy of relative immunodominance,
in the context of multideterminancy, was suggested from our ear-
lier studies employing single residue glycine substitutions with the
DPAF epitope of peptide PS1CT3 (14). To further confirm that the
former does, indeed, impact upon the latter, we synthesized three
additional analogues of peptide PS1CT3. In one, Asp (4) was re-
placed with an Asn residue (peptide PS1CT3N31), whereas Phe
(7) was substituted for Leu in another (peptide PS1CT3L34). The
FIGURE 3. Arrhenius plots of the association reaction of the interaction
between monomeric IgM mAbs and peptide PS1CT3. Natural log values of
association rate constants of monomeric IgM mAbs 7bM (x), 42M (F),
8aM (E), and 19M () at various temperatures (see Materials and Meth-
ods) are plotted against 1/T 3 1023. T represents the temperature in
degrees Kelvin. All rate constants are the mean values of three indepen-
dent runs. Slopes yield the Ea for the association step for each monomeric
IgM mAb.
Table II. Thermodynamic parameters regulating association of antigen
with monomeric IgMa
mAb
DHass
(kJM21)
DSass
(JK21M21)
DGass
(kJM21)
7bM 233.98 2286.53 50.91
42M 227.68 2272.07 53.40
8aM 248.68 2361.37 59.00
19M 278.06 2450.75 56.26
a Ea for the association of each of the monomeric IgM mAbs listed here were
determined as the slopes of the Arrhenius plots shown in Fig. 3. From this, the
enthalpy (DHass), entropy (DSass), and Gibbs-free energy (DGass) changes accompa-
nying the association reaction were calculated using equations 1 to 3 described in
the text.
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third analogue represented a doubly substituted peptide where both
Asp (4) and Phe (7) were substituted with Asn and Leu residues,
respectively (peptide PS1CT3N31L34). The rationale for such
substitutions was to specifically alter the chemical nature of the
corresponding residue side chains, but without significantly affect-
ing their steric bulk. The side chain areas for Asp and Asn are 106
A2 and 113 A2, respectively, whereas those for Phe and Leu are
175 A2 and 137 A2 (25).
In preliminary experiments, separate groups of mice were im-
munized with the individual peptides and the consequent peptide-
specific IgM Abs were isolated from sera collected 7 days later.
Monomeric derivatives were then prepared (see Materials and
Methods), and relative avidity for the homologous peptide was
determined by competitive inhibition ELISA experiments. These
experiments yielded IC50 values of 14 6 3 mM, 72 6 8 mM, 64 6
5 mM, and 88 6 9 mM for anti-PS1CT3, anti-PS1CT3N31, anti-
PS1CT3L34, and anti-PS1CT3N31L34 monomeric IgM prepara-
tions, respectively. Thus, the avidity of primary recognition is in-
deed influenced by the amino acid composition of Ag.
We next immunized mice with an equimolar mixture of peptide
PS1CT3 and the three analogues described above. Since all of
these peptides encode a common T cell epitope (segment CT3),
immunization with the mixture was expected to result in activation
of diverse B cells directed against determinants presented by the
individual peptides, but all requiring help from a common pool of
CT3-specific Th cells. In other words, such a system would sim-
ulate the situation obtained with more complex multideterminant
Ags presenting a wide array of B cell epitopes. For comparative
purposes, additional groups of mice were also immunized with the
individual peptides. The subsequent IgG responses, obtained 4 wk
later, were then analyzed and the data are presented in Fig. 4. An
intriguing dichotomy can be noted in immunogenicity of the an-
alogue peptides when immunized individually, as opposed to im-
munization in a mixture (Fig. 4). Individual immunizations yielded
comparable IgG levels for all four peptides (Fig. 4a). In contrast,
immunogenicity of these analogues was markedly suppressed, rel-
ative to that of PS1CT3, in the mixture (Fig. 4b). This attenuation
of immunogenicity of the analogues, in a mixture, is well in keep-
ing with the poorer avidity of monomeric IgM responses elicited
by them in comparison to that against the parent peptide PS1CT3.
The results described so far, therefore, cumulatively argue for
the existence of a correlation between the chemical composition of
an epitope, the avidity of its recognition in an early primary re-
sponse, and the resultant effect on relative immunodominance, in
the context of multideterminancy, in the later stages of the
response.
Hierarchical contribution of individual amino acid residues
toward epitopic dominance
We also adopted an alternate strategy to further confirm the exis-
tence of a relationship between chemical composition of an
epitope on a multideterminant Ag and its position in the hierarchy
of relative immunodominance in a humoral response. For this, we
synthesized analogues of peptide PS1CT3 where the amino-termi-
nal His residue was independently replaced with each of the 19
remaining naturally occurring a amino acid residues. As shown
earlier (14, 19, 28), the amino-terminal PS1-derived hexapeptide
normally represents a cryptic determinant in the primary anti-
PS1CT3 IgG response. Our objective, therefore, was to assess the
efficacy of each of the various substitutions in creating a novel
amino-terminal epitope. It was anticipated that such an approach
would also provide information as to whether individual residues
do in fact contribute variably toward immunogenicity of a given
epitope on a multideterminant Ag.
Subsequent to synthesis of these N-terminal substituted ana-
logues of peptide PS1CT3, we first ensured that these changes did
not lead to any secondary structural changes in the resulting mol-
ecule. This was achieved by circular dichroism (CD) spectroscopy.
As earlier described, peptide PS1CT3 exists in a random distribu-
tion of conformations in solution (14, 27). This “randomness” was
found to be unaffected in all analogues synthesized, and CD spec-
tra of representatives are shown in Fig. 5. Although CD studies do
not provide information on subtle changes in structure, these re-
sults nevertheless confirm that the substitutions performed did not
lead to imposition of any gross structural constraint.
The amino-terminal substituted analogues of peptide PS1CT3
were separately immunized into BALB/c mice, and the resulting
IgG responses were analyzed for distribution of epitope-fine spec-
ificities. This was achieved by screening against appropriate over-
lapping hexapeptide panels derived either from PS1 or its analo-
gous segment. Fortunately for us, in all cases, the polyclonal IgG
response was found to be restricted toward the amino-terminal half
of the PS1 segment. There was no appearance of any reactivity
toward the carboxyl-terminal half of the sequence, the only vari-
able between the analogues being the extent of cross-reactivity
with the amino-terminal hexapeptide. Where detected, the latter
reactivity always depended on the presence of the appropriate,
homologous, residue at the amino terminus, as substitution with
any other completely abrogated this reactivity (data not shown).
Following this initial screen, the relative proportion of DPAF-spe-
cific vs amino-terminal hexapeptide-specific Abs in the sera were
estimated by saturation inhibition ELISA experiments with homol-
ogous and the parent PS1CT3 peptide.
A representative analysis for three separate substitutions is
shown in Fig. 6. It is evident from the data presented that the
FIGURE 4. Relative immunodominance of peptides PS1CT3 and its
DPAF-substituted analogues. Groups of five mice each were immunized
with 10 nmol/mouse each of either peptide PS1CT3 (peptide1),
PS1CT3N31 (peptide 2), PS1CT3L34 (peptide 3), or PS1CT3N31L34
(peptide 4). Four weeks later, the mice were bled, sera within a group were
pooled, and peptide-specific IgG titers were estimated by quantitative
ELISA (a). A parallel group of mice was also immunized with a mixture
containing 10 nmol/mouse of each of the above peptides, followed by
determination of individual peptide-specific IgG titers 4 wk later (b). Data
are from one of two separate experiments.
5619The Journal of Immunology
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
proportion of amino-terminal reactivity obtained is, indeed, depen-
dent on the nature of substitution performed at the N-terminal po-
sition. Thus, the presence of an Arg residue at this position was
most conducive for a maximal shift in immunodominance away
from the DPAF epitope and toward the amino terminus (Fig. 6). In
contrast, substitution for a Gly residue at this position had no sig-
nificant effect (Fig. 6).
To rationalize the distinctions observed in Fig. 6, and in light of
the observations in Tables I and II, we reasoned that any variable
effects of individual amino acid residues would probably emanate
from nonidentical contributions of their side chains, toward ener-
getically stabilizing complexation with the corresponding Ab. In
principle, this argument could also be extended to binding of an
epitope with the sIg receptors on specific B cells. Therefore, to
explore for such a possible correlation, we also calculated the total
potential free energy that each of the 20 various amino acid residue
side chains can contribute in a binding interaction (see Materials
and Methods). The cumulative comparison of values thus obtained
for each residue, with its effect on relative immunodominance of
the amino-terminal hexapeptide segment is shown in Table III. A
general correlation between the potential energetic contribution of
side chain of a given residue toward binding and the proportion of
shift in immune recognition toward the amino terminus is dis-
tinctly evident (Table III). All residues with side chain DG values
of negativity $5.0 induced a significant shift in Ab specificity
toward amino-terminal recognition. In contrast, those with DG val-
ues of negativity #4.0 proved ineffective in this regard (Table III).
To confirm that the observed differences in Table III do correlate
with differences in avidity of primary recognition, primary IgM
responses were obtained against a representative set of peptides
described in Table III. These preparations were then resolved for
Abs specific for the amino-terminal segment vs those directed
against the remainder of the sequence by sequential affinity chro-
matography. Resulting IgM fractions were reduced to their mono-
meric forms, and the relative avidity of these preparations for the
homologous peptide was determined by competitive inhibition
ELISA. Results from such experiments are given in Table IV. It is
clear that those substitutions which yielded a significant shift in
epitopic immunodominance toward the amino terminus in Table
III were also those that produced amino-terminal-specific mono-
meric IgM Abs of an avidity that was significantly higher than that
obtained against the rest of the sequence (Table IV). In contrast,
substitutions that had a minimal effect on epitope specificity of the
IgG response elicited cognate monomeric IgM Abs of avidities
that were indistinguishable from that generated against the rest of
the sequence (Table IV).
The influence of amino acid composition of epitope is limited by
accessibility of its side chains
A notable discrepancy with the hierarchy shown in Table III was
that of the parent peptide PS1CT3. Although results presented both
here and earlier (14, 19, 28) demonstrated that the amino-terminal
segment constituted a cryptic determinant in primary responses,
this was incompatible with the estimated value of DGtotal of
26.275 for the His side chain (Table III). To explore the basis for
this, we examined the 1H-nuclear magnetic resonance (NMR)
spectrum of peptide PS1CT3. Intriguingly, we observed here that
FIGURE 5. CD spectra of representative amino-terminal-substituted
analogues of peptide PS1CT3. CD spectra, obtained at 6 mM concentra-
tions in PBS, of peptide PS1CT3 (—) or its analogues containing amino-
terminal substitutions with either Arg (– z –), Trp (– zzz –), or Gly (–) are
shown. Spectra were recorded on a Jasco model J710 spectropolarimeter
(Jasco, Tokyo, Japan) over a wavelength range of 200–250 nm. A step
resolution of 0.1 nm and a scan speed of 200 nm/min were employed.
Spectra shown are those averaged over a total of 30 accumulations. FIGURE 6. Characterization of late-stage primary IgG responses to rep-
resentative amino-terminal-substituted analogue peptides. A, An analysis
for distribution of epitope-fine specificities by screening against the ho-
mologous overlapping hexapeptide panel by ELISA (see Materials and
Methods). Sera used were obtained at day 42 after a primary immunization
of mice with each peptide. The x-axis denotes each hexapeptide as its
N-terminal residue, except in the first position (identified as X) which
represents the appropriate amino-terminal substitution in each of these
cases. B, The results of a saturation inhibition ELISA for the above serum
preparation using either the homologous analogue peptide (F) or peptide
PS1CT3 (E) as the competitive inhibitor (see Materials and Methods).
Results shown are from one of three experiments from independent im-
munizations. Analogues for which data are shown here are those containing
amino-terminal substitutions of either Arg (a), Trp (b), or Gly (c). Data for
the parent peptide, PS1CT3, are shown in d.
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signals for the protons at C2 and C4 positions of the imidazole ring
of His were shifted significantly downfield from the expected val-
ues (32). As shown in Fig. 7A, signal for the proton at the C2
position appears at 8.73 ppm, whereas that for the C4 proton ap-
pears at 7.36 ppm. These signals are downfield of the correspond-
ing shifts obtained for these same protons even when His residues
are present in a highly acidic environment (32). Thus, the deshield-
ing of ring protons seen in Fig. 7A reveals a significantly decreased
electronegative character for the side chain imidazole ring of His
in peptide PS1CT3.
Although a variety of interactions could account for the ob-
served deshielding of the His side chain, a detailed analysis by CD
spectroscopy revealed that the PS1 segment in peptide PS1CT3
was resistant to imposition of any structural constraints, even in the
presence of high (up to 50%) concentrations of the secondary
structure enhancing solvent trifluoroethanol (data not shown, but
see Ref. 33). Although not conclusive, these results, nevertheless,
suggested to us that this deshielding was probably not due to long-
range interactions. Another possible explanation that was consid-
ered was that of short-range hydrogen-bonding interactions be-
tween the protonated a amine group of the N-terminal His and the
nitrogen atoms of the imidazole ring. We tested this possibility by
synthesizing a derivative of peptide PS1CT3 where the terminal
amino group was acetylated. This capping of the a amino func-
tionality of the terminal His residue was expected to disrupt any
such intramolecular interactions.
Amino-terminal acetylation of peptide PS1CT3 did, in fact, re-
sult in an upfield shift of both the imidazole protons at the C2 and
C4 positions, as revealed by 1H-NMR spectroscopy (Fig. 7, C and
D). Thus, although the precise mode remains unclear, amino-ter-
minal acetylation of peptide PS1CT3 results in an increased elec-
tronegative character for the His side chain. Parallel groups of
mice were then immunized either with the parent peptide PS1CT3
or its acetylated derivative. Sera obtained 6 wk later were subse-
quently analyzed for both distribution of epitope specificities and
relative proportion of N-terminal-reactive Abs as described for
Fig. 6. The native peptide, as expected (14, 19, 28), elicited an
anti-DPAF monospecific response. In contrast, however, the poly-
clonal IgG derived against the acetylated derivative displayed sig-
nificant amino-terminal reactivity, both by epitope-mapping and
saturation inhibition protocols (Fig. 8). As shown in Table III, the
relative proportion of N-terminal reactivity in the acetylated pep-
tide was well in keeping with the calculated DG value for the His
side chain.
Discussion
Antigenicity of individual determinants on a polypeptide Ag is
generally thought to constitute a surface static property of the Ag
(35, 36). Such a notion stems from the joint realization of the
plasticity of the preimmune B cell repertoire and the fact that B
cells generally recognize Ags in their native form. Consequently,
attempts at ab initio identification of B cell epitopes have primarily
focused on structural aspects of polypeptide Ags. These analyses
rely on assessment of individual domains either for their surface
accessibility, flexibility, or structural propensity (37–41). How-
ever, although both repertoire plasticity and a requirement for
epitope accessibility cannot be denied, our own earlier results in-
dicate that the spectrum of epitopes recognized in an Ag-specific
humoral response constitutes only a fraction of that which may be
anticipated (13–15). These studies have demonstrated that, subse-
quent to the initial recognition of Ag, immunological parameters
are soon brought into play to restrict the range of epitope-specific
responses that are retained (13–18). Of the diverse clonotypes ac-
tivated upon first exposure to Ag, these selection processes ensure
that only those B cells with highest affinity for Ag are selected for
seeding of GCs and consequent retention in the response (14).
Table III. Effect of N-terminal substitutions on relative immunogenicity
of the amino-terminal determinanta
Substituted
Residue
N-terminal
Reactivity
(% of total)
Side Chain DGtotal
(kcal/mol)
Arg 85 6 4 29.900
Lys 80 6 7 29.175
Glu 76 6 5 28.450
Asp 66 6 8 27.825
Hisb 54 6 6 26.275
Trp 55 6 6 26.125
Tyr 43 6 9 25.675
Phe 38 6 7 25.075
Met 11 6 3 24.000
Ile 13 6 4 23.500
Gln 10 6 4 23.450
Leu 12 6 3 23.425
Val 11 6 3 22.925
Asn NDc 22.825
Pro NDc 22.625
Cys NDc 22.600
Thr NDc 22.550
Ser NDc 22.000
Ala NDc 21.675
Gly NDc 0.0
a As described in the text, N-terminal-substituted analogues of peptide PS1CT3
were immunized in BALB/c mice and pooled sera were collected at day 42 for sub-
sequent analysis as shown in Fig. 6. The extent of inhibition with the parent peptide
PS1CT3 was taken to represent the proportion of Abs directed against amino-termi-
nal-independent epitopes. By subtraction of this, the relative proportion of Abs di-
rected to the amino-terminal epitope (expressed as percentage of total Abs) was then
calculated. Data for the His residue were obtained from immunization with the acety-
lated peptide PS1CT3. Values are the means (6SD) of determinations with at least
three independently derived serum preparations from groups of five mice each. Side
chain DGtotal values were calculated as described in Materials and Methods.
b N-terminal reactivity results shown are for the acetylated derivative of peptide
PS1CT3 (see text).
c ND, Not detectable.
Table IV. Relative avidities of N-terminal-specific primary monomeric
IgM Abs in representative analoguesa
N-Terminal
Substitution
IC50 of Monomeric IgMs Against (mM)
N terminus Othersb
Arg 2.1 6 1.2 28.0 6 8.0
Asp 4.2 6 2.3 22.0 6 6.4
Trp 9.4 6 3.2 34.0 6 8.3
Gln 32 6 5.0 32 6 6.8
Ser 31 6 3.6 24 6 5.0
Ala 28 6 4.0 26 6 6.0
a Groups of 20 BALB/c mice each were individually immunized with each of the
amino-terminal-substituted analogues of peptide PS1CT3 listed here. One week later,
blood was collected and sera within a group were pooled. Each serum preparation was
then depleted of any IgG Abs using protein G-Sepharose as described in Materials
and Methods. After this, Abs directed against determinants common to the parent
PS1CT3 sequence were first purified by two rounds of affinity chromatography over
a matrix coupled to peptide PS1CT3 (Materials and Methods). Subsequently, amino-
terminal-specific IgM Abs were also purified from the flow through fraction by two
rounds of affinity chromatography over a matrix coupled to the homologous peptide
(Materials and Methods). The two individual IgM fractions, for each peptide, were
concentrated and reduced to monomeric IgM as described in Materials and Methods.
Relative avidities of the monomer IgM fractions for the homologous peptide were
determined by competitive inhibition ELISA, with preparations normalized for an Ab
concentration of 2.0 mg/ml (Materials and Methods). Results shown are a represen-
tative of two independent experiments, and values for IC50 are the means (6SE) of
triplicate determinations.
b Indicates Abs directed against determinants common to the parent peptide
PS1CT3 (i.e., that IgM fraction which bound to a peptide PS1CT3-containing
column).
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Thus, the pre-GC phase selection appears to constitute the first
and, perhaps critical, filtering step in the pathway that defines se-
quential progression of humoral responses.
An intriguing corollary noted in these above studies was that
clonotype selection in the pre-GC phase also translates into re-
striction of epitope specificities. Thus, for example, the early pri-
mary response to peptide PS1CT3 always resulted in exclusive
selection for B cells directed against a single tetrapeptide epitope
of sequence DPAF (14). The consequences of this selection was
exercised upon subsequent stages where both late primary IgG and
the Ag-specific memory B cell pool were monospecific for the
DPAF epitope (17). At least in the context of peptide PS1CT3,
these findings suggested that the affinity/avidity of preimmune B
cell responses to individual epitopes may not be stochastically gen-
erated but, perhaps, could be associated with at least some degree
of determinism. However, the factors, if any, that controlled such
an outcome proved especially enigmatic since a variety of predict-
able parameters such as surface accessibility, mouse H-2 haplo-
type, secondary structural propensities, and positional influences
could be ruled out as probable causes (13–15, 19). Interestingly
though, single residue glycine substitutions within the DPAF
epitope was found to result in a redistribution of epitope specific-
ities in favor of alternate determinants within the PS1 segment,
although the avidity of the resulting responses were markedly re-
duced. These latter results provided a possible clue by implicating
that the affinity/avidity of a primary response to a multideterminant
Ag may be epitope dependent.
Although somewhat unusual, the above proposal is not alto-
gether untenable if one considers the fact that the affinity of
interaction of Ag with either Ab or sIgM receptor on B cells
directly relates to the Gibbs-free energy of complexation (DG)
by the equation, DG 5 2RTlnKd. Here Kd represents the equi-
librium dissociation constant. In this context, it is pertinent to
recall that, as demonstrated for a variety of systems (17, 42–
44), Ag-Ab interactions in the early primary response do not
involve idealized surface complementarity. Rather, this is sub-
sequently achieved by the combined processes of somatic mu-
tation and positive selection within GCs (45– 47). Conse-
quently, the role of the chemical composition of an epitope in
defining the energetics and thereby the affinity of its interaction
with a stochastically generated receptor on preimmune B cells
could not be excluded.
FIGURE 7. One-dimensional and two-dimensional proton NMR spectra of peptide PS1CT3 and its acetylated analogue. Three hundred MHz proton
NMR spectra of peptide PS1CT3 (A and B) and its amino-terminal acetylated derivative (C and D) were acquired in D2O at a final concentration of 10 mM
at 25°C, after exchange of labile amide protons. A and C, The region between 7 and 9 ppm in the one-dimensional spectra. Chemical shifts were measured
relative to the internal standard 3-(trimethylsilyl)propionic acid, sodium salt (DSS). Positions of C2 and C4 protons of the imidazole ring of His side chain
are indicated. B and D, The 300-MHz 1H COSY (2D correlation spectroscopy) spectrum of the corresponding regions shown in A and C. While the C2H
of the His side chain is characteristic (32), C4H was identified by cross-peak connectivities (shown by the dashed line) between the distinct diagonal peaks.
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Support for such a possibility was afforded by our examination
of monomeric IgM mAbs derived against the PS1 segment of pep-
tide PS1CT3. As already indicated, our choice of monomeric IgMs
was based on the expectation that they would be reminiscent of the
sIgM receptor on preimmune B cells from which they were de-
rived. At one level, it was interesting to note that a diverse range
of affinity constants were obtained, with some Abs yielding values
for Ka as low as 104 M21. Although this confirms our earlier pro-
posal that Ag-driven preimmune B cell activation involves low
thresholds (18), they further add by revealing that Ag-binding af-
finity constants of as low as 104 M21 suffice to induce preimmune
B cells into a primary response. Another important highlight of
these results was the comparable affinities displayed by Abs di-
rected against a given epitope that, at least in some instances, was
independent of their clonal origins. Consequently, the hierarchy of
Ab affinities obtained also distinguished between independent
epitopes recognized on the PS1 segment; implicating epitope de-
pendency of monomeric IgM Ab affinity.
A rationale for the above findings was provided by our subse-
quent thermodynamic analysis of the association process between
Ag and monomeric IgMs. Regardless of either clonal origin or
epitope specificity of Ab, these studies identified that the driving
force for this process derived exclusively from net favorable
changes in enthalpy and occurred at the expense of an overall
decrease in the entropy of the system. Although the entropy
changes probably reflect conformational readjustments within the
paratope of Ab, the negative enthalpy changes clearly point to the
dominant contributions from epitope-paratope interface interac-
tions in rendering this association permissible. Thus, a synthesis of
these two lines of evidence permits the inference that, by influ-
encing the nature of interface interactions, the chemical composi-
tion of an epitope represents at least one parameter that defines the
affinity of its binding to either its corresponding monomeric IgM
mAb or, by extension, the sIgM receptor on cognate preimmune B
cells.
Although these studies provided an insight into the physico-
chemical forces driving Ag recognition by preimmune B cells and
distinctions arising therein, the functional relevance of these dis-
tinctions remained to be validated. One approach to resolving this
employed isosteric substitutions for chemically dissimilar residues
within the DPAF epitope of peptide PS1CT3. This permitted gen-
eration of analogues that, upon immunization, yielded primary mo-
nomeric IgM Abs of markedly reduced avidities relative to that
obtained against the native peptide. Interestingly, immunization
with equimolar mixtures of these analogue peptides and peptide
PS1CT3 resulted in a marked suppression in immunogenicity of
the analogues relative to the parent peptide. These results provided
empirical evidence in favor of a causal link between avidity of
primary recognition and immunogenicity in the later stages of the
response.
The dependence of immunogenicity of an epitope on its amino
acid composition could also be unequivocally demonstrated with
analogues of peptide PS1CT3 incorporating various substitutions
at the amino terminus. Amino-terminal substitutions were pre-
ferred on the basis that alteration at this position was least likely to
impose any structural influences. Thus, depending upon whether,
for example, the amino-terminal residue was Gly or Arg, the re-
sulting primary IgG response displayed the extreme situations
from a cryptic amino-terminal segment to one where this domain
was the most immunodominant. Furthermore, by using the anti-
DPAF response as an internal comparative standard, we were also
able to delineate a hierarchy for individual amino acid residues in
terms of their relative ability to render the amino-terminal segment
immunogenic. Interestingly, in addition to underscoring the non-
identical contributions from individual residues, this hierarchy was
found to correlate well with the potential energetic contribution of
each amino acid side chain, defined as calculated Gibbs-free en-
ergy changes, toward a binding interaction. Thus, while the exper-
imental data in Table III clarify a role for amino acid constituents
of epitope in defining its relative immunogenicity, the correlation
with side chain DG values supports that this role derives from
energetic considerations. Experimental support for this correlation
could be provided, at least for some of the analogues, by compar-
ing avidities of primary monomeric IgMs obtained against the ami-
no-terminal epitope vs that obtained against the remainder of the
sequence. Whereas those substitutions that enhanced immunoge-
nicity of the amino-terminal epitope also yielded amino-terminal-
specific monomer IgMs of higher relative avidity, this was not true
of those that had no significant effect.
More recently, we have also examined the frequency of occur-
rence of individual amino acid residues as anchor residues within
epitopes described in the literature (V. Manivel and K. V. S. Rao,
unpublished results). Such a frequency analysis revealed an over-
whelming preference, as anchor residues, for amino acid residues
with side chain DG values of negativity .5.0 (as defined in Table
III) (V. Manivel and K. V. S. Rao, unpublished results). These
results further support the proposal that delineation of functional B
cell epitopes from the array presented by a multideterminant Ag is
driven by thermodynamic considerations.
Thus, in summary, divergent lines of evidence presented in this
report highlight some important operating principles governing the
early stages of a humoral response to T-dependent multidetermi-
nant Ags. First, the initial encounter with Ag results in activation
of an array of B cell clonotypes against diverse epitopes and with
varying affinities for Ag. Although this was not unexpected, what
was surprising, however, was the near complete dependence of
affinity on epitope recognized, as also its independence from the
clonal origins of Ab. This dependence appears to derive from ther-
modynamic considerations, an analysis of which revealed yet an-
other interesting facet of Ag recognition by preimmune B cells. At
least for peptide PS1CT3, binding to the B cell receptor on pre-
immune B cells was found to involve large conformational
changes within the paratope of receptor. As a result, association
FIGURE 8. Primary IgG response to the acetylated derivative of peptide
PS1CT3. Groups of mice were immunized with the amino-terminal acety-
lated derivative of peptide PS1CT3 (see text), and sera were collected 42
days later. The separated IgG fraction from this serum was then analyzed
for distribution of epitope specificities against the PS1-derived hexapeptide
panel as described for Fig. 6. Results are shown in A. B, The results of a
saturation inhibition ELISA performed for the same IgG preparation using
either the homologous acetylated peptide (F) or peptide G28CT3 (E) as
the competitive inhibitor. Peptide G28CT3 represents a nonacetylated an-
alogue of PS1CT3 where the amino-terminal His was substituted for Gly.
As shown earlier (28), this peptide competes as effectively as the native
nonacetylated peptide PS1CT3 for anti-PS1CT3 Abs, with near identical
IC50 values.
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was allowed only if the gain resulting from paratope-epitope in-
terface interactions could sufficiently compensate for this. It is per-
tinent to recall here that Ag recognition by preimmune B cells
differs from bindings observed for classical receptor-ligand pairs
that regulate biological responses. Although the latter generally
represents systems where both partners have coevolved for ideal-
ized complementarity over biological time, the former constitutes
a search for the best available fit by scanning through a library of
“imperfect” receptors. Similarly, Ag recognition in a primary re-
sponse is also distinct from that in a secondary IgG response, the
latter not requiring unfavorable changes in paratope conformation
(V. Manivel, N. Samoo, and K. V. S. Rao, manuscript in prepa-
ration). Thus, in a situation where the feasibility of an induced fit
is defined by the enthalpy of the reaction, it is not surprising that
the chemical composition of an epitope plays an important role.
Epitope-dependent distinctions in Ab affinity in the early pri-
mary response are functionally significant in that they impact upon
the hierarchy of epitopic dominance observed in the later stages of
the response. This is presumably achieved by mechanisms eluci-
dated earlier (14, 16–18), wherein seeding of GCs is restricted to
the highest affinity B cell subsets which, consequently, also leads
to a restriction in epitope specificities. We emphasize here that
these studies are not intended to permit prediction of functional B
cell epitopes on multideterminant Ags. Indeed, given that the
three-dimensional structure of most Ags is unknown, as also the
fact that the influence of chemical composition of epitope is lim-
ited by accessibility of its side chains for interaction with Ab, any
prediction is clearly not possible at this stage. Nonetheless, the
relevance of our present investigations lie in elucidating mecha-
nisms that govern the initiating step in Ag-driven optimization of
T-dependent humoral responses.
In previous studies, we had shown that, at least in the context of
peptide epitopes, Ab optimization for epitope within GCs was
driven in favor of increased on-rates of Ag binding (19). Interest-
ingly, this kinetic control of clonotype selection in GCs was found
to correlate with increased Ag specificity because it facilitated dis-
crimination between conformational variants of the same epitope
(19). These earlier results, in conjunction with the present data,
therefore reveal that maturation of Ag-specific T-dependent hu-
moral responses occurs in two discrete sequential stages. The first,
which is under thermodynamic control, constitutes a selection for
the best of available fits between the spectrum of epitopes on Ag
and the repertoire of receptors on preimmune B cells. This is then
followed by a further optimization, within GCs, of this selected
subset for the kinetics of Ag/epitope binding. It is probably due to
the concerted action of these two processes, that the twin imposing
demands of high affinity and exquisite fidelity are so rapidly
achieved in T-dependent humoral responses.
Acknowledgments
We are grateful to Dr. R. P. Roy (National Institute of Immunology) for use
of his CD spectrophotometer.
References
1. Colman, P. M. 1988. Structure of antibody-antigen complexes: implications for
immune recognition. Adv. Immunol. 43:99.
2. Paige, C. J., and G. E. Wu. 1989. The B cell repertoire. FASEB J. 3:818.
3. Benjamin, D. C., J. A. Berzofsky, I. J. East, F. N. Gurd, C. Hannum, S. J. Leach,
E. Margoliash, J. G. Michael, A. Miller, E. M. Prager, et al. 1984. The antigenic
structure of proteins: a reappraisal. Annu. Rev. Immunol. 2:67.
4. Berzofsky, J. A., L. K. Richman, and D. J. Killon. 1979. Distinct H-2 linked Ir
genes control both antibody and T cell responses to different determinants on the
same antigen, myoglobin. Proc. Natl. Acad. Sci. USA 76:4046.
5. Herzenberg, L. A., and T. Tokuhisha. 1982. Epitope-specific regulation. I. Carrier
induction of suppression for IgG anti-hapten antibody responses. J. Exp. Med.
155:1730.
6. Sadegh-Nasseri, S., D. E. Knipp, B. A. Taylor, A. Miller, and E. E. Sercarz. 1984.
Selective reversal of H-2 linked genetic unresponsiveness to lysozymes. I. Non-
H-2 genes closely linked to Ir-2 locus on chromosome 2 permits an anti-lysozyme
response in H-2b mice. Immunogenetics 20:535.
7. Wicker L. S., C. D. Benjamin, A. Miller, and E. E. Sercarz. 1984. Immunodom-
inant protein epitopes. II. The primary antibody response to hen egg white ly-
sozyme requires and focuses upon a unique N-terminal epitope. Eur. J. Immunol.
14:447.
8. Sadegh-Nasseri, S., V. Dessi, and E. E. Sercarz. 1986. Selective reversal of H-2
linked genetic unresponsiveness to lysozymes. II. Alteration in T helper/T sup-
pressor balance owing to genes linked to Ir-2 leads to responsiveness in BALB/c.
Eur. J. Immunol. 16:486.
9. Manca, F., D. Fenoglio, A. Kunkl, C. Cambiaggi, L. Pira, and F. Celada. 1988.
B cells on the podium: regulatory roles of surface and secreted immunoglobins.
Immunol. Today 9:300.
10. Gajewski, T. F., J. Joyce, and F. W. Fitch. 1989. Antiproliferative effect of IFN-g
in immune regulation. III. Differential selection of TH1 and TH2 murine helper
T lymphocyte clones using recombinant IL-2 and recombinant IFN-g. J. Immu-
nol. 143:15.
11. Kunkl, A., D. Fenoglio, F. Manca, L. Pira, and F. Celada. 1992. Kinetic immu-
nodominance: functionally competing antibodies against exposed and cryptic
epitopes of Escherichia coli b-galactosidase are produced in time sequence. Int.
Immunol. 4:627.
12. Scheerlick, J. Y., R. DeLeys, E. Saman, L. Brys, A. Geldhoff, and
P. D. Bactselier. 1993. Redistribution of a murine humoral response following
removal of an immunodominant B cell epitope from a recombinant fusion pro-
tein. Mol. Immunol. 30:733.
13. Vijayakrishnan, L., V. Kumar, J. N. Agrewala, G. C. Mishra, and K. V. S. Rao.
1994. Antigen-specific early primary humoral responses modulate immunodomi-
nance of B cell epitopes. J. Immunol. 153:1613.
14. Agarwal, A., S. Sarkar, C. Nazabal, G. Balasundaram, and K. V. S. Rao. 1996.
B cell responses to a peptide epitope. I. The cellular basis for restricted recog-
nition. J. Immunol. 157:2779.
15. Tuteja R., A. Agarwal, L. Vijaykrishnan, B. P. Nayak, S. K. Gupta, V. Kumar,
and K. V. S. Rao. 1997. B cell responses to a peptide epitope. II. Multiple levels
of selection during maturation of primary responses. Immunol. Cell Biol. 75:245.
16. Agarwal, A., B. P. Nayak, and K. V. S. Rao. 1998. B cell responses to a peptide
epitope. VII. Antigen-dependent modulation of the germinal center reaction.
J. Immunol. 161:5832.
17. Nayak, B. P., A. Agarwal, P. Nakra, and K. V. S. Rao. 1999. B cell responses to
a peptide epitope. VIII. Immune complex mediated regulation of memory B cell
generation within germinal centers. J. Immunol. 163:1371.
18. Agarwal, A., and K. V. S. Rao. 1997. B cell responses to a peptide epitope. III.
Differential T helper cell thresholds in recruitment of B cell fine specificities.
J. Immunol. 159:1077.
19. Nayak, B. P., R. Tuteja, V. Manivel, R. P. Roy, R. A. Vishwakarma, and
K. V. S. Rao. 1998. B cell responses to a peptide epitope. V. Kinetic regulation
of repertoire discrimination and antibody optimization for epitope. J. Immunol.
161:3510.
20. Merrifield, R. B. 1986. Solid phase synthesis. Science 232:341.
21. Stewart, J. M., and J. D. Young. 1984. Solid Phase Peptide Synthesis, 2nd Ed.
Pierce Chemical Co., Rockford, IL.
22. Atherton, E., and R. C. Sheppard. 1989. Solid Phase Peptide Synthesis: A Prac-
tical Approach. IRL Press, Oxford, U.K.
23. Geysen, H. M., S. J. Rodda, T. J. Mason, G. Tribbick, and P. G. Schoofs. 1987.
Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods 102:
259.
24. Johnstone, A., and R. Thorpe. 1996. Immunochemistry in Practice, 3rd Ed.
Blackwell Scientific, Oxford, U.K., p. 83.
25. Novotny, J., and K. Sharp. 1992. Electrostatic fields in antibodies and antibody/
antigen complexes. Prog. Biophys. Mol. Biol. 58:203.
26. Miller, S., J. Janin, A. M. Lesk, and C. Chothia. 1987. Interior and surface of
monomeric proteins. J. Mol. Biol. 196:641.
27. Anderson, D. E., W. J. Becktel, and F. W. Dahlquist. 1990. pH-Induced dena-
turation of proteins: A salt bridge contributes 3–5 kcal/mol to the free energy of
folding of T4 Lysozyme. Biochemistry 29:2403.
28. Vijayakrishnan, L., S. Sarkar, R. P. Roy, and K. V. S. Rao. 1997. B cell responses
to a peptide epitope. IV. Subtle changes in flanking residues modulate immuno-
genicity. J. Immunol. 159:1809.
29. Janin, J. 1995. Protein-protein recognition. Prog. Biophys. Mol. Biol. 64:145.
30. Janin, J. 1995. Principles of protein-protein recognition from structuremto ther-
modynamics. Biochimie 77:497.
31. Thomas, C. J., B. P. Gangadhar, N. Surolia, and A. Surolia. 1998. Kinetics and
mechanism of recognition of endotoxin by polymixin. B. J. Am. Chem. Soc.120:
12428.
32. Wuthrich, K. 1986. NMR of Proteins and Nucleic Acids. Wiley, New York.
33. Vijayakrishnan, L., V. Manivel, and K. V. S. Rao. 1998. B cell responses to a
peptide epitope. VI. The kinetics of antigen recognition modulates B cell-medi-
ated recruitment of T helper subsets. J. Immunol. 161:4661.
34. Novotny, J. 1991. Protein antigenicity: a thermodynamic approach. Mol. Immu-
nol. 28:201.
35. Novotny, J., M. Hanschumacher, and R. E. Bruccoleri. 1987. Protein antigenicity:
a surface static property. Immunol. Today 8:26.
36. Amzel, J. M., and B. J. Gaffney. 1995. Structural immunology: problems in
molecular recognition. FASEB J. 9:7.
5624 THERMODYNAMIC CONTROL OF EPITOPE SELECTION
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
37. Berzofsky, J. A. 1985. Intrinsic and extrinsic factors in protein antigen structure.
Science 229:932.
38. Van Regenmortel, M. H. V. 1990. Structure of viral epitopes. In Immunochemistry of
Viruses. II. The Basis for Serodiagnostics and Vaccines. M. H. V. Van Regenmortel and
A. R. Neurath, eds. Elsevier Science, Amsterdam, p. 1.
39. Novotny, J., M. Handschumacher, E. Haber, R. E. Bruccoleri, W. B. Carlson,
D. W. Fanning, J. A. Smith, and G. D. Rose. 1986. Antigenic determinants co-
incide with surface regions accessible to large probes (antibody domains). Proc.
Natl. Acad. Sci. USA 83:226.
40. Novotny, J., R. E. Bruccoleri, W. D. Carlson, M. Handschumacher, and E. Haber.
1987. Antigenicity of myohemerythrin. Science 238:1584.
41. Geysen, M. H., J. Tainer, S. J. Rodda, T. J. Mason, H. Alexander, E. D. Getzoff,
and R. A. Lerner. 1987. Chemistry of antibody binding to a protein. Science
235:1184.
42. Arevalo, J. H., C. A. Hassig, E. A. Stura, M. J. Taussig, and I. A. Wilson. 1994.
Structural analysis of antibody specificity. J. Mol. Biol. 241:663.
43. Wong, Y. W., P. H. Kussie, B. Parhami-Seren, and M. N. Margolies. 1995.
Modulation of antibody affinity by an engineered amino acid substitution. J. Im-
munol. 154:3351.
44. Torigoe, H., T. Nakayama, M. Imazato, I. Shimada, Y. Arata, and A. Sarai. 1995.
The affinity maturation of anti-4-hydroxy-3-nitrophenylacetyl mouse monoclonal
antibody: a calorimetric study of the antigen-antibody interaction. J. Biol. Chem.
270:22218.
45. Berek, C., and M. Zeigner. 1993. The maturation of the immune response. Im-
munol. Today 14:400.
46. Nossal, G. J. V. 1994. Differentiation of the secondary B lymphocyte repertoire:
the germinal center reaction. Immunol. Rev. 137:173.
47. Manser, T., K. M. Tumas-Brundage, L. P. Casson, A. M. Guisti, S. Hande,
E. Notidis, and K. A. Vora. 1998. The role of antibody variable region hyper-
mutation and selection in the development of the memory B-cell compartment.
Immunol. Rev. 162:182.
5625The Journal of Immunology
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
